J Matthew Singleton - Net Worth and Insider Trading
J Matthew Singleton Net Worth
The estimated net worth of J Matthew Singleton is at least $591,850 dollars as of 2024-06-02. J Matthew Singleton is the Director of Viking Therapeutics Inc and owns about 9,500 shares of Viking Therapeutics Inc (VKTX) stock worth over $591,850. Details can be seen in J Matthew Singleton's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that J Matthew Singleton has not made any transactions after 2018-05-31 and currently still holds the listed stock(s).
Transaction Summary of J Matthew Singleton
J Matthew Singleton Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, J Matthew Singleton owns 1 companies in total, including Viking Therapeutics Inc (VKTX) .
Click here to see the complete history of J Matthew Singleton’s form 4 insider trades.
Insider Ownership Summary of J Matthew Singleton
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VKTX | Viking Therapeutics Inc | 2018-05-31 | director |
J Matthew Singleton Latest Holdings Summary
J Matthew Singleton currently owns a total of 1 stock. J Matthew Singleton owns 9,500 shares of Viking Therapeutics Inc (VKTX) as of May 31, 2018, with a value of $591,850.
Latest Holdings of J Matthew Singleton
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VKTX | Viking Therapeutics Inc | 2018-05-31 | 9,500 | 62.30 | 591,850 |
Holding Weightings of J Matthew Singleton
J Matthew Singleton Form 4 Trading Tracker
According to the SEC Form 4 filings, J Matthew Singleton has made a total of 0 transactions in Viking Therapeutics Inc (VKTX) over the past 5 years. The most-recent trade in Viking Therapeutics Inc is the acquisition of 9,500 shares on May 31, 2018, which cost J Matthew Singleton around $93,290.
Insider Trading History of J Matthew Singleton
- 1
J Matthew Singleton Trading Performance
GuruFocus tracks the stock performance after each of J Matthew Singleton's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by J Matthew Singleton is 30.83%. GuruFocus also compares J Matthew Singleton's trading performance to market benchmark return within the same time period. The performance of stocks bought by J Matthew Singleton within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how J Matthew Singleton's insider trading performs compared to the benchmark.
Performance of J Matthew Singleton
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -5.01 | | | | | |
| Relative Return to S&P 500(%) | -5.49 | | | | | |
J Matthew Singleton Ownership Network
J Matthew Singleton Owned Company Details
What does Viking Therapeutics Inc do?
Who are the key executives at Viking Therapeutics Inc?
J Matthew Singleton is the director of Viking Therapeutics Inc. Other key executives at Viking Therapeutics Inc include Chief Financial Officer Greg Zante , Chief Operating Officer Marianna Mancini , and director & President & CEO Brian Lian .
Viking Therapeutics Inc (VKTX) Insider Trades Summary
Over the past 18 months, J Matthew Singleton made no insider transaction in Viking Therapeutics Inc (VKTX). Other recent insider transactions involving Viking Therapeutics Inc (VKTX) include a net sale of 748,415 shares made by Brian Lian , a net sale of 187,095 shares made by Greg Zante , and a net sale of 531,730 shares made by Marianna Mancini .
In summary, during the past 3 months, insiders sold 348,181 shares of Viking Therapeutics Inc (VKTX) in total and bought 0 shares, with a net sale of 348,181 shares. During the past 18 months, 1,615,026 shares of Viking Therapeutics Inc (VKTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,615,026 shares.
Viking Therapeutics Inc (VKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Viking Therapeutics Inc Insider Transactions
J Matthew Singleton Mailing Address
Above is the net worth, insider trading, and ownership report for J Matthew Singleton. You might contact J Matthew Singleton via mailing address: 286 Stanwich Road, Greenwich Ct 06830.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
